Hsa_circRNA_100791 Modulates Trim13 Through Sponging miR-487b-5p to Facilitate Inflammation in Allergic Rhinitis
Jianhua Wu,Yisha Wu,Peng Jin,Xiaoxue Zi,Yuzhu Wan,Kaiyue Sun,Li Shi,Deyun Wang
DOI: https://doi.org/10.2147/jir.s485165
IF: 4.5
2024-12-18
Journal of Inflammation Research
Abstract:Jianhua Wu, 1, 2 Yisha Wu, 1 Peng Jin, 3 Xiaoxue Zi, 3 Yuzhu Wan, 1 Kaiyue Sun, 1, 4 Li Shi, 1, 3 Deyun Wang 5 1 Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial ENT Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People's Republic of China; 2 Department of Otolaryngology Head and Neck Surgery, Binzhou People's Hospital, Binzhou, Shandong, People's Republic of China; 3 Department of Otolaryngology, The Second Hospital of Shandong University, Jinan, Shandong, People's Republic of China; 4 Department of Physiology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People's Republic of China; 5 Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore Correspondence: Li Shi, Department of Otolaryngology, The Second Hospital of Shandong University, Jinan, Shandong, 250033, People's Republic of China, Tel +86 0531 83086278, Fax +86 0531 83086279, Email Kaiyue Sun, Department of Physiology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250022, People's Republic of China, Tel +86 0531 83086277, Fax +86 0531 83086279, Email Background: Circular RNAs (circRNAs) are a novel class of endogenous non-coding RNA molecules in eukaryotes, involved in many essential biological processes. However, their role in allergic rhinitis (AR) has not been extensively studied. Methods: The expression levels of hsa_circRNA_100791 were measured using qRT-PCR in peripheral blood mononuclear cells (PBMCs) and nasal mucosa from AR patients. The biological function of hsa_circRNA_100791 in AR was investigated through RNA-seq and a series of in vitro experiments. Western blotting, luciferase reporter assays, and rescue experiments were conducted to elucidate the molecular mechanisms underlying hsa_circRNA_100791. Additionally, a mouse model was used to assess the functional role of hsa_circRNA_100791 in vivo. Results: Upregulation of hsa_circRNA_100791 was observed in both PBMCs and nasal mucosa of AR patients. In vitro, increased expression of hsa_circRNA_100791 promoted the production of pro-inflammatory mediators (IL-1β, IL-4, IL-5, IL-6, IL-8, IL-13, IL-17, IL-18, IL-33, TNF-α, and NF-κB) and inhibited IL-2 and IFN-γ. Conversely, knockdown of hsa_circRNA_100791 both in vitro and in vivo alleviated AR symptoms, reduced pro-inflammatory mediators, and enhanced IL-2 and IFN-γ levels. Mechanistically, we found hsa_circRNA_100791 contributing to the pathological processes of AR, which upregulate TRIM13 via sponging miR-487b-5p. Conclusion: Our study demonstrated that hsa_circRNA_100791 mitigates the inhibitory effect of miR-487b-5p on Trim13 by directly binding to miR-487b-5p. This interaction regulates the expression of inflammatory factors and facilitates AR. Thus, hsa_circRNA_100791 could be a promising new therapeutic target for AR. Keywords: allergic rhinitis, hsa_circ_100791, miR-487b-5p, Trim13, diagnosis, inflammation, NF-κB AR is one of the most common chronic airway diseases, characterized by IgE-mediated type 2 inflammation in response to inhaled allergens. Clinically, AR presents with nasal congestion, itching, sneezing, and rhinorrhea. 1,2 During acute allergic reactions, inflammatory mediators primarily released by mast cells (eg histamine and leukotrienes) are responsible for the development of AR symptoms. Additionally, activated allergen-specific TH2 cells secrete large amounts of IL-4, IL-5, and IL-13, which contribute to the enhancement and persistence of type 2 mucosal inflammation in AR. 1–3 However, the specific molecular and cellular mechanisms underlying these processes are not yet fully understood. MicroRNAs (miRNAs) are small non-coding RNA molecules that can decrease gene expression either by degrading mRNA or by binding to the 3ʹ-untranslated region of target mRNAs to inhibit translation. 4 Several studies have suggested that miRNAs play a role in the pathological processes of AR. 5–7 For instance, miR-133b has been reported to alleviate allergic symptoms in a mouse model of AR. 7 Additionally, miR-487b has been shown to mitigate AR in an OVA-induced animal model by inhibiting the IL-33/ST2 signaling pathway, and reduced expression of miR-487b can lead to increased production of pro-inflammatory cytokines such as IL-6 and TNF-α. 5 Furthermore, miR-487b is known to play a significant role in allergic airway inflammation. 8 Despite these insights, the precise molecular mechanisms underlying -Abstract Truncated-
immunology